Markets
Markets Open Ahead Of Fed Chairman Powell's Afternoon Remarks On Interest Rates
Photo by Michael M. Santiago/Getty Images
Déjà vu

Roaring Kitty is posting again and GameStop is surging again

Luke Kawa
5/13/24 8:18AM

There’s something unusual going on in shares of GameStop right meow.

On Sunday evening, Keith Gill, aka The Roaring Kitty aka DeepFuckingValue, tweeted an image of someone leaning forward in their chair.

What are we supposed to be paying attention to? Well, this:

Gill was the guru of the GameStop moment that saw shares of the beleaguered video game retailer rise almost 800% over the span of just five days in January 2021, while a hedge fund that bet against the company lost 53% during the month. 

For years, he was a fixture on social media. On YouTube (as The Roaring Kitty), he explained the fundamental arguments for his long positions in GameStop, first initiated in June 2019. In the r/wallstreetbets subreddit (as u/DeepFuckingValue),  he provided monthly updates of his positioning along with more color commentary. Gill had done the due diligence (or ‘DD’ in wallstreetbets parlance) that others were happy to use as the intellectual justification for their own frenzied buying of GameStop shares and call options as the stock began to rise.

As Gill would later say in testimony before Congress, “I like the stock.”

Last week, Gill also “liked” a post on X, formerly Twitter, from the movie “Run Lola Run”, which has been interpreted on some message boards as blessing the idea that GameStop shares have room to run to the upside.

So far, this is a faint echo of the 2021 (and even 2022) levels of price action and activity in GameStop.

What’s the same as 2021? Shares of GameStop are surging, and it doesn’t have much to do with any perceived positive change in the company’s operations. 

(Based on the price action, it’s clear that Gill’s return to social media, even without saying a word, has people feeling better about the stock’s prospects, if not the company’s).

What’s different? As of the end of April, GameStop has more short interest as a percent of equity float (24%) than most stocks – but it’s a far cry from the more than 100% of shares sold short entering 2021, before the stock went parabolic.

In other words, there’s less potential buying power from people who have to admit they were wrong and close up bets against the stock if it goes up this time.

GameStop reports earnings on June 7.

More Markets

See all Markets
markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

markets

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

markets

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.